The Veteran's bladder disability and residuals of prostate cancer are being remanded for additional development to determine if they were caused by VA treatment or exposure to Agent Orange.,New evidence has been received regarding the Veteran's claims, but further examination is needed to assess whether his current conditions are related to his service.
The deciding factor: The Veteran's bladder disability and residuals of prostate cancer may be related to his service due to potential exposure to Agent Orange. However, this needs to be evaluated with additional medical evidence.
- Claimed conditions
- Bladder disability, Residuals of prostate cancer
- How they argued it
- Not specified
- Exposure basis
- Agent Orange / herbicides
- Rating assigned
- None in this decision
- Decision date
- October 23, 2019
- Citation
- A19002215
Veterans Law Judge
Decisions by this judge: 1,858 · Granted: 24% (granted or partly granted, in the vetted decisions on this site)
Judge attribution: 2025 complete; earlier years partial.
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation A19002215.
What this means for you
A remand is not a loss. The Board sent the case back for more development — often a new exam or missing records — before making a final decision. Many remands later end in a grant, and the decision spells out exactly what the Board wanted to see.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Partly granted
The Board granted service connection for a bladder disability but denied service connection for an acquired psychiatric disorder, to include PTSD and a depressive disorder.
- Denied
The Board denied an earlier effective date for service connection of residuals of prostate cancer, finding that the August 10, 2022 effective date is appropriate under the PACT Act.
- Remanded (sent back)
The Board remands the claims for a rating reduction and increased rating for prostate cancer, as well as the TDIU claim, due to the need for additional development of evidence.
- Denied
The Board denied service connection for residuals of testicular, prostate, and lung cancer as the conditions were not incurred during a period of ACDUTRA and are not related to any in-service injury or disease.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.